D68.5 Primary thrombophilia

Name of the Condition

• Primary Thrombophilia

Summary

Primary thrombophilia is a group of inherited or acquired conditions that increase the risk of abnormal blood clot formation (thrombosis). These disorders affect the balance of coagulation factors, anticoagulant proteins, or platelet function, leading to a predisposition for venous or arterial clots.

Causes

Primary thrombophilia arises from genetic or acquired factors that disrupt normal hemostasis. Common inherited causes include deficiencies in anticoagulant proteins (e.g., antithrombin, protein C, protein S) or mutations in coagulation factor genes (e.g., Factor V Leiden, prothrombin gene mutation). Acquired causes may involve autoantibodies or other underlying conditions.

Risk Factors

• Family history of thrombosis
• Inherited genetic mutations affecting coagulation
• Prolonged immobility or surgery
• Hormonal changes (e.g., pregnancy, oral contraceptives)
• Advanced age or obesity
• Certain medical conditions (e.g., cancer, inflammatory disorders)

Symptoms

• Unexplained swelling, pain, or redness in limbs
• Recurrent deep vein thrombosis (DVT) or pulmonary embolism (PE)
• Chronic leg pain or skin discoloration
• Shortness of breath or chest pain (if PE occurs)
• Unexplained miscarriages (in some cases)

Diagnosis

Diagnosis involves clinical evaluation, family history, and laboratory testing. Tests may include genetic screening for mutations, measurement of anticoagulant protein levels, or coagulation assays to assess clotting function. Imaging studies (e.g., ultrasound) may confirm thrombosis.

Treatment Options

• Anticoagulant medications (e.g., heparin, warfarin, DOACs) to prevent clot formation
• Lifestyle modifications to reduce risk factors
• Regular monitoring of clotting parameters during therapy
• Prophylactic treatment for high-risk situations (e.g., surgery)

Prognosis and Follow-Up

With appropriate management, prognosis is generally good. Follow-up includes regular monitoring of anticoagulant therapy, assessment of clotting risk, and adjustments to treatment based on clinical status. Long-term management focuses on preventing recurrent thrombosis.

Complications

• Recurrent venous or arterial thrombosis
• Post-thrombotic syndrome (chronic limb pain/swelling)
• Pulmonary hypertension (from recurrent PE)
• Increased risk of pregnancy complications
• Potential bleeding risks from anticoagulant therapy

Lifestyle & Prevention

• Maintain a healthy weight and regular physical activity
• Avoid prolonged immobility; move during travel or bed rest
• Stay hydrated and avoid smoking
• Discuss hormonal therapy risks with a healthcare provider
• Consider prophylactic anticoagulation for high-risk situations

When to Seek Professional Help

Seek immediate care for symptoms of DVT (leg swelling, pain) or PE (chest pain, shortness of breath). Consult a healthcare provider for unexplained bruising, recurrent clots, or family history of thrombophilia.

Tips for Medical Coders

Document the specific thrombophilia type (e.g., Factor V Leiden, protein C deficiency) when available, as it may influence coding specificity. Note any associated conditions (e.g., pregnancy, surgery) that contribute to thrombotic risk. Ensure documentation supports the diagnosis and any related complications for accurate coding.